Clinical Trial Simulations : Applications and Trends /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2011.
|
| Edición: | 1st ed. 2011. |
| Colección: | AAPS Advances in the Pharmaceutical Sciences Series,
1 |
| Materias: |
Tabla de Contenidos:
- Clinical Trial Simulation and Quantitative Pharmacology
- Contribution of Modeling and Simulation Studies in the Regulatory Review: A European Regulatory Perspective
- Contribution of Modeling and Simulation in the Regulatory Review and Decision-Making: U.S FDA Perspective
- Decision-Making in Drug Development: Application of a Model Based Framework for Assessing Trial Performance
- Decision-Making in Drug Development: Application of a Clinical Utility Index
- Adaptive Trial Designs
- Keys of Collaboration to Enhance Efficiency and Impact of Modeling and Simulation
- Leveraging Pharmacometrics in Early Phase Anti-Inflamatory Dug Development
- The Application of Drug-Disease Models in the Development of Anti-Hyperglycemic Agents
- Modeling and Simulation in the Development of Cardiovascular Agents
- Viral Dynamic Modeling and Simulations in HIV and Hepatitis C
- A Model-Based PK/PD Antimicrobial Chemotherapy Drug Development Platform to Simultaneously Combat Infectious Diseases and Drug Resistance
- PKPD and Disease Modeling: Concepts and Applications to Oncology
- Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Erythropoietic Stimulating Agents
- Model Based Development of an Agent for the Treatment of Generalized Anxiety Disorder
- Balancing Efficacy and Safety in the Clinical Development of an Atypical Antipsychotic, Paliperidone Extended-Release
- Application of Modeling and Simulation in the Development of Protein Drugs
- Modeling and Simulation in Pediatric Research and Development
- Disease Progression Analysis: Towards Mechanism-Based Models
- Using a Systems Biology Approach to Explore Hypotheses Underlying Clinical Diversity of the Renin Angiotensin System and the Response to Antihypertensive Therapies
- Recent Developments in Physiologically Based Pharmacokinetic Modeling
- Covariate Distribution Models in Simulation.